ATRA vs CCL · rev $128.9M vs P/E 15, rev $25.02B
Atara Biotherapeutics Inc (ATRA) versus Carnival Corporation (CCL) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Carnival Corporation (CCL) is a travel services company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported CCL revenue for 2024-11-30 was $25.02B. Net income was $1.92B. Revenue was up 15.9% from 2023-11-30 to 2024-11-30. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
ATRA currently screens at market cap $87.1M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Not investment advice. Open the ATRA and CCL stock pages for the full models.
Not investment advice.